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Abstract: The present work aims to reveal the pharma-industrial benefits of the use of
hydrothermally synthesised titanate nanotube (TNT) carriers in the manufacturing of nano-sized
active pharmaceutical ingredients (APIs). Based on this purpose, the compressibility and
compactibility of various APIs (diltiazem hydrochloride, diclofenac sodium, atenolol and
hydrochlorothiazide) and their 1:1 composites formed with TNTs were investigated in a comparative
study, using a Lloyd 6000R uniaxial press instrumented with a force gauge and a linear variable
differential transformer extensometer. The tablet compression was performed without the use of
any excipients, thus providing the precise energetic characterisation of the materials’ behaviour
under pressure. In addition to the powder functionality test, the post-compressional properties of
the tablets were also determined and evaluated. The results of the energetic analysis demonstrated
that the use of TNTs as drug carriers is beneficial in every step of the tabletting process: besides
providing better flowability and more favourable particle rearrangement, it highly decreases the
elastic recovery of the APIs and results in ideal plastic deformation. Moreover, the post-compressional
properties of the TNT–API composites were found to be exceptional (e.g., great tablet hardness and
tensile strength), affirming the above results and proving the potential in the use of TNT carriers for
drug manufacturing.
Keywords: titanate nanotube; diltiazem hydrochloride; diclofenac sodium; atenolol; hydrochlorothiazide;
composite; compressibility
1. Introduction
Titanate nanotubes (TNTs) are recently explored nanomaterials with special physicochemical
properties and versatile applicability, from engineering [1–5] to therapeutic use [6–10].
Based on the synthesis method, two types of TNTs can be distinguished, anodized and
hydrothermally synthesised, of which both have a particular tubular shape and show good
physicochemical stability [11,12]. Focusing on pharmaceutical applications, these characteristics
indicate that TNTs can be filled with drugs, and may serve as drug carriers for therapeutic use.
In this regard, anodized TNTs, which are surface attached carriers, may beneficially be used in
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implantology [13–15], while hydrothermally synthesised TNTs, which are separate carriers, can be
loaded and/or functionalized with active substances [16,17] and provide a large spectra of drug
delivery approaches. Concentrating on hydrothermally synthesised TNTs, it is important to underline
that these nano-materials are completely biocompatible and assure safe use without any toxicity
risks, as discussed in several studies [18,19]. This property makes them much more valuable for
nanomedicine than many other nano-materials, e.g., carbon nanotubes, and necessitates the detailed
pharmaceutical investigation of TNTs.
In our previous study [20], hydrothermally synthesised TNTs were characterised based on
their ability to be incorporated with active pharmaceutical ingredients (API). A 1:1 weight ratio
of API–hydrothermally synthesised titanate nanotube (API–TNT) composites were prepared and
investigated in terms of morphology, surface free energy, thermal properties, API–TNT bonds and
drug release. In general, composite formation may bear numerous advantages, such as improved
mechanical properties, better stability, electrochemical properties or biocompatibility [21,22]. Based on
this, our hypothesis was that the composite formation may stabilize the tested APIs in nanocrystalline
form, improve their processability, prevent auto-aggregation and therefore improve the dissolution
profile of the APIs. It was seen that TNTs were suitable to be loaded with drugs, however, the efficacy
of API incorporation depended on the API characteristics, e.g., diltiazem hydrochloride and diclofenac
sodium could completely fill the TNTs, while the incorporation of atenolol and hydrochlorothiazide
was only partially achievable. Based on the results, hydrogen bonds were the main interactions between
the APIs and the TNTs which, together with other findings, proves that the efficacy of the composite
formation, and the strength of association, were mainly defined by the hydrogen donor capacity
of the incorporated APIs. In the case of important association, as seen for diclofenac sodium–TNT
composites, the composite formation was shown to affect the drug dissolution and result in modified
drug release, which suggests the implementation of composite containing modified-release tablets.
Based on the characteristics of TNTs, and the fact that the tablet is still the most popular dosage
form on the patients’ part and is also the most frequently chosen form by industry, it is truly worth
focusing on the innovative tabletting solutions titanate nanotubes may provide. First of all, a great
advantage of API–TNT composites is that the API is kept in a nano-sized form inside the tubes, and is
therefore protected from autoaggregation. As a result, TNTs offer the opportunity of improving
the solubility of the incorporated API, thereby leading to better bioavailability. At the same time,
composite formation may offer the realisation of controlled drug release, due to the position of the
API inside the tube and the bonds forming between the APIs and the TNTs as mentioned above.
Besides these approaches, another important aspect of the composites is worth pointing out: while the
manufacturing of an API requires precise knowledge about powder properties and requires detailed
investigations, API–TNT composites may ease and shorten the preformulation studies and make the
tabletting process easily predictable, since the composites presumably will behave similarly in spite of
carrying different APIs.
With the purpose of confirming the statement described above, the present study aimed to
investigate the compressibility and compactibility of API–TNT composites, and reveal the advantages
they can bring. In order to be able to draw useful and correct conclusions, four different APIs
and their composites formed with TNTs were examined and compared regarding their mechanical
properties. The powder compression mechanisms of materials are usually estimated by fitting data
into mathematical (Heckel [23,24], Walker [25] and Kawakita-Lüdde [26]) models, which are widely
used in the field of pharmaceutical technology [27–29]. However, it is notable that, besides some
critical issues [30], these models describe only a given part of the compression cycle, and need to
be combined with each other to give a complete view of the process. Moreover, these equations
are based on the volume/density reduction of the powder bed, which may hide some important
parts of the compression process, especially if they are calculated according to the out-die method.
Accordingly, we decided to apply a less known but certainly more detailed and complex method to
reveal the energetic background behind the behaviour of TNT based nanomaterials under compression
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pressure. The measurements of the present study were therefore performed with a Lloyd 6000R uniaxial
press instrumented with a force gauge and a linear variable differential transformer extensometer,
which allowed thorough analysis of the whole compression cycle of the pure materials. Moreover,
the post-compressional properties of the tablets could also be determined with the same equipment and
taken into consideration. The suitability of this methodology has already been proven by the work of
Viana et al. In comparing the compression performance of different types of celluloses [29]. The present
work attempted to test the powder functionality of various API–TNT composites, and thereby
investigate a completely unexplored but quite reasonable aspect of these composites, which may
open new directions in the tabletting of nano-sized APIs.
2. Materials
Diltiazem hydrochloride (DiltHCl), diclofenac sodium (DicNa), atenolol (ATN) and
hydrochlorothiazide (HCT) were kindly supplied by Sanofi-Aventis PLC (Budapest, Hungary),
Egis Pharmaceuticals PLC (Budapest, Hungary), TEVA Pharmaceuticals PLC (Debrecen, Hungary
and Gedeon Richter PLC (Budapest, Hungary), respectively. Hydrothermally synthesised titanate
nanotubes (TNT) and 1:1 weight ratio composites of APIs and TNTs (abbreviated with DiltTi, DicTi,
ATNTi and HCTTi for dilthiazem hydrochloride, diclofenac sodium, atenolol and hydrochlorothiazide
containing composites, respectively) were produced by the University of Szeged, Department of
Applied and Environmental Chemistry according to the method described by Sipos et al. [20].
In general, a 1:1 ratio of alcoholic API solution and the same 1:1 ratio of alcholic TNT dispersion
were mixed and subjected to an hour-long ultrasonic treatment, followed by removal of solvent in
a vacuum dryer (Figure 1) [20]. This method resulted in a perfect composite formation for DiltHCl
and DicNa, where the API was incorporated into the tubular structure or attached to the surface of
the TNTs in nanocrystalline form. In the case of HCT, a reverse composite formation was observed,
where the TNTs were attached to the surface of the re-crystallising HCT, while for ATN the composite
formation was unsuccessful and, due to the weakness of interaction, the composite acted like a physical
mixture of the API and TNTs (Figure 2) [20].
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3. ethods
Following the method introduced by Viana et l. [31] for powder functionality, the c mpressibility
of the TNTs, APIs and API–TNT composites was investigated using a Lloyd 6000R uniaxial press
(Ametek SAS Lloyd Inst, Elanc urt, France), instrume t d wi h a force gauge and a linear variable
d ff rential transform r extensometer. The equipm nt provided the tablett ng of the samples wi out
using any excipient , and th refor allowed thorough investigation of the behaviour components
under compression pressure. The compacts were prepared in a 1 cm3 stainless steel cell with manual
filling, using 50, 100, 150, 200 and 250 MPa pressures for each material. The weight of the powder was
determined using the bulk ensity of the u packed powders. A minimum of 3 tablets per compression
pressure were made from each component, with a tabletting punch speed of 1 mm/sec. Force and
displace ent data were processed by a computer (R-Control software, Version 2.0, Lloys Inst LTD,
Fareham, UK) connected to the equipment.
3.1. Packing oefficie t
The packing coefficient ( t, ) as calculated using Equation (1), on the basis of the obtained
force–displace ent data of at least 10 co pacts per aterial.
Ct = ((H0−H0.5)/H0) × 100 (1)
where H0 is the height of the initial powder bed and H0.5 is the height of the powder bed at 0.5 MPa
compression pressure. This value gives information about the particle rearrangement in the initial
phase of the compression process, and correlates with the Compressibility Index and the Hausner
Ratio. It indicates the densification behaviour of a powder at low pressure as follows: Ct > 30.0 %
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displays bad particle rearrangement, Ct < 25.0 % refers to optimal behaviour and a value in between
indicates fair densification properties [31].
3.2. Energetic Analysis
The energetic analysis describing the energy utilisation of the materials during the compression
cycle was evaluated with Origin 7.5 software (OriginLab Corporation, Northampton, MA, USA),
and aimed to determine the energies displayed in Figure 3. The total mechanical energy (MCW)
involved in the compression process (ABC triangle) is composed of four partial energy segments:
packaging energy (PW), friction energy (FW), net energy (NCW) and elastic energy (EW), which are
used in the initial packaging of the particles, particle–particle and particle–die frictions during
densification, plastic and elastic deformations respectively. With the subtraction of PW (ABA’ triangle,
where A’ is the smallest displacement of punch that generates measurable force) from the MCW,
the theoretical energy (ThCW) (A’BC triangle) may be calculated, which is related to the energy utilised
for powder compaction. If the FW (A’BA’ curved area) is subtracted from the ThCW itself, we may
calculate the total energy (TCW) (A’BC curved area) of the deformations. The TCW can be further
segmented to the net energy (NCW) (A’BD curved area), utilised for plastic deformations, and elastic
energy (EW) (DBC curved area), which is gained by elastic recovery of the particles.
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The determined energies were normalised to compact weight, and used to estimate the linear
interrelations between given energies and their change all over the applied compression pressure
range [31].
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The following Ri and their complementary R’i yields signify the pressure related transformation
of MCW into ThCW (R1) and PW (R’1), the ThCW into TCW (R2) and FWC (R’2), and the TCW into
NCW (R3) and EW (R’3), calculated by applying Equations (2)–(7), respectively:
R1 = ∆ThCW/∆MCW (2)
R’1 = 1−(∆ThCW-∆MCW) (3)
R2 = ∆TCW/∆ThCW (4)
R’2 = 1−(∆TCW/∆ThCW) (5)
R3 = ∆NCW/∆TCW (6)
R’3 = 1−(∆NCW/∆TCW) (7)
R1 is related to the packaging ability of the materials, and represents the remaining energy in
percentage after the initial rearrangement of the particles in the first phase of compression. R2 is
indicative of the frictions in the second phase of compression, while R3 and R’3 display the percentage
of the plastic and elastic deformation energies of the materials, respectively. In consequence, R3 equals
the plasticity of the materials, calculated according to Stamm and Mathis [32].
The efficacy of the conversion of net energy into cohesion during compression was investigated by
the efficacy coefficient (Ceff, %), defined as the slope of the linear part of the (BW) = f(NCW) function
plot, where BW is the breaking energy discussed below. A value superior to 0.1% indicates good
energy utilisation of the material [31].
A general view on the powder behaviour under pressure, showing the ability of the material to
be compacted by the direct compression method, was given by the global yield (RT, %), which was
determined by Equation (8):
RT = R1 × R2 × R3 × Ceff (8)
3.3. Post-Compressional Properties
The determination of tablet properties can help to estimate the efficiency of the tabletting process,
and thereby can be used to complete and confirm the results of the energetic measurements.
The geometric parameters of the tablets were tested 24 h after ejection by investigating 3 tablets
per pressure per component. The height of the tablets was measured with a calliper, while the diameter
was determined as part of the breaking test. The as measured geometric parameters served to define
the compaction ratio ($, %) of the compacts using Equation (9):
$ = (dcompact/dpycno) × 100 (9)
where dcompact is the density of the tablet after ejection and dpycno is the density of the initial powder
determined by a pycnometer. The pycnometric density was defined using an AccuPyc 1330 pycnometer
(AccuPyc 1330 series No. 2441, Micromeritics Instruments Inc., Norcross, GA, USA). Measurements
were repeated until the value stabilised [33].
The breaking test of the tablets was performed in standing tablet posture with the Lloyd 6000R
uniaxial press. The measurements of breaking force and tablet diameter provided force–displacement
rupture plots, which were used to determine the breaking energy and tensile strength. A typical
rupture of the API–TNT composites is seen in Figure 4. The breaking energy (BW, J·g−1) was obtained
from Equation (10):
BW = OEG/m (10)
where OEG is the area under the curve of the breaking process and m is the mass of the tablet.
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The tensile strength (Rd, MPa) of the tablets was defined by applying Equation (11):
Rd = 2Fmax/pidh (11)
where Fmax is the breaking force in N, d is the diameter, and h is the thickness in mm of the tablet
after ejection.Materials 2018, 11, x FOR PEER REVIEW  8 of 15 
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4. Results and Discussion
4.1. Packing Coefficient
The packing coefficients (Table 1) allowed understanding and comparison of the particle
rearrangement properties of the materials in the initial phase of the compression process.
Table 1. Packing coefficient of the materials.
Material Ct (%)
TNT 7.81
DiltHCl 58.42
DiltTi 10.57
DicNa 59.64
DicTi 18.02
ATN 60.04
ATNTi 20.03
HCT 46.24
HCTTi 22.45
It is remarkable that TNTs showed an excellent Ct value, far below 10.0%, despite the needle
shaped crystal character, which was certainly due to the roundish agglomerates they form [20]
(see Supplementary Materials) playing a driving role in the rheological properties. Moreover,
the rearrangement profile of the API–TNT composites was also much more favourable than that
of the pure APIs. Although the positive effect of composite formation on the packing character of
the incorporated APIs was clear, the rate of the influence differed by API, resulting in the following
order of Ct improvement: DiltHCl > DicNa > ATN > HCT. This result can be explained by the
structure of the composite products presented in a previous study [20]. For DiltHCl and DicNa, where
the composite formation was perfect, the properties of TNTs completely dominated the packaging
properties; the different improvement rate may be due to the different agglomeration mechanisms
resulting in different surface coverage of the TNTs with the API. In the case of ATN, the TNTs were
intercalated between the API particles, while for HCT the moderate improvement may be due to the
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increase in the surface free energy and adhesivity of the composite, since here the TNTs formed the
outer layer.
4.2. Energetic Analysis
Figures 5–7 present the plots of the energetic analysis of TNT, DicNa and DicTi products, and are
good representatives of the other investigated APIs and composites as well (other curves may be
seen in Supplementary Materials). It can be seen that all the curves are linear, however, outstanding
differences can be seen in the slope of the curves. In order to quantify and compare these differences,
Ri and R’i values were determined from the slope of (ThCW) = f(MCW), (TCW) = f(ThCW) and (NCW)
= f(TCW) plots. The results are summarised in Table 2. R’i values may be calculated according to 100
− Ri equation.
The results obtained by the investigation of the Ct are well supported by the analysis of the
conversion of mechanical energy into theoretical energy (Figure 5). The high slope means that only
a small proportion of the applied MCW is lost on the initial particle rearrangement and converted
into ThCW.
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lower surface free energy the APIs displayed relatively high R2 values, indicating modest energy
loss to friction during compression. Regarding the composites, it may be observed that the slope of
curve is highly related to the surface coverage and consequential surface free energy of the various
composites (see Supplementary Materials). For those composites where the TNTs were covered with
drug nanocrystals (DicTi (Figure 6) and DiltTi), the slopes were parallel with those of the pure APIs,
while the behaviour of HCTTi was predominated by the characteristics of TNTs, supporting the
6 l ti f total energy (T theoretical energy (ThCW) of TNT, DicNa and DicTi at
50, 100, 150, 200 and 250 MPa compression pressure.
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Table 2. Energetic parameters of titanate nanotubes (TNTs), active pharmaceutical ingredients (APIs)
and TNT–API composite powders.
Material R1 (%) R2 (%) R3 (%) Ceff (%) Rt (%)
TNT 88.65 16.32 82.87 0.314 0.0376
DiltHCl 22.44 30.44 76.26 0.216 0.0113
DiltTi 82.26 29.79 88.15 0.132 0.0285
DicNa 25.52 29.52 59.16 0.017 0.0008
DicTi 76.36 31.32 89.38 0.185 0.0395
ATN 26.38 10.18 45.50 0.131 0.0046
ATNTi 74.17 21.46 71.5 0.043 0.0049
HCT 34.3 32.45 80.49 0.093 0.0083
HCTTi 67.25 28.34 82.31 0.268 0.0420
The very high R1 value of the pure TNTs indicates good flowability and favourable particle
rearrangement. In contrast, small R1 values were observed for all APIs, which is related to the
considerable energy loss on packaging and rearrangement of the particles due to poor flowability
and high adhesivity, which made the experiments extremely hard to accomplish. As concerns the
composite products, it is noteworthy that the plots of the (ThCW) = f(MCW) function of the composites
display a comparable rise of curve with the pure TNTs instead of the incorporated APIs (Figure 5),
supporting their good flowability and packaging ability. Nevertheless, it is important to note that the
R1 values belonging to the composites showed the same differences in comparison with the TNTs
as was observed for the packaging coefficient, and these are due to differences in the efficacy of the
incorporation process.
In order to identify the energy dissipated to friction, TCW vs. ThCW plots were evaluated
(Figure 6).
The low R2 values (Table 2) of the pure TNTs indicate an ineffective conversion of theoretical
energy into total energy, due to a massive energy loss caused by friction under pressure. This may
be evoked by the high surface free energy of the TNTs (80.72 mJ/m2) [20]. In contrast, due to their
lower surface free energy the APIs displayed relatively high R2 values, indicating modest energy
loss to friction during compression. Regarding the composites, it may be observed that the slope of
curve is highly related to the surface coverage and consequential surface free energy of the various
composites (see Supplementary Materials). For those composites where the TNTs were covered with
drug nanocrystals (DicTi (Figure 6) and DiltTi), the slopes were parallel with those of the pure APIs,
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while the behaviour of HCTTi was predominated by the characteristics of TNTs, supporting the
properties discussed before. The unexpected behaviour of ATNTi, which showed a decreased rate
of friction compared to both the pure API and the TNTs, may be explained by weak hydrophilic
interactions between the API and the nanotubes, resulting in more hydrophobic characteristics of this
physical mixture like composite.
Plotting the (NCW) = f(TCW) function served to investigate the conversion of the total energy into
net energy (Figure 7), where the high slope and the resulting R3 values indicate plastic deformation
without considerable elastic recovery.
High R3 values were obtained for TNTs and composites, which indicates that the good plastic
deformation of TNTs may highly improve this property of the APIs with composite formation. This was
especially remarkable in the case of DicNa, where the lamination of the tablets compressed from the
pure API was clearly visible above 150 MPa, indicating considerable elastic recovery after compression.
Similar good results were observed for DiltHCl, but considerably lower values may be observed for
the ATNTi and HCTTi composites, indicating that the rate of improvement strongly depends on the
success of the composite formation process. In the case of incomplete incorporation of the API into
the TNTs, the physical properties of the drug may predominate the behaviour of composites, but the
improvement in the results of the strongly elastic ATN indicates that the presence of TNTs may have a
positive effect on this characteristic, even if they are presented in the form of a physical mixture.
Overall, it can be concluded that composite formation highly improved the compression properties
and energy utilisation during compression, due to better flowability and particle rearrangement
and improved plasticity of the incorporated APIs, which presumes better post-compressional tablet
properties. Interestingly, the less favourable property of the TNTs (low R2 value) did not dominate
in the composite products, therefore no substantial negative effects of composite formation could be
revealed by the measurements. However, it is noteworthy that the rate of the positive impact provided
by the TNTs was considerably affected by the efficacy of the incorporation process.
4.3. Post-Compressional Properties
The good post-compressional properties of tablets are essential for many manufacturing and
pharmacological aspects. In addition, tablet properties can also serve to estimate the efficacy of the
tabletting process, which—in our case—refers to the compactibility of the given materials. Therefore,
post-compressional attributes were used to confirm the results of the energetic analysis. The compaction
ratios were determined from the results of the tablet geometry measurements and the previously
performed pycnometric examinations, while breaking tests were used to define the tensile strength of
the tablets (Table 3).
The results indicate an opposing behaviour of the various APIs and the TNTs against compression.
TNTs have poor compressibility (only 50% compaction ratio at low compression force) but have
good compactibility (constantly increasing tensile strength and densification in the 50 to 250 MPa
compression pressure range). In contrast, pure APIs have appropriate compressibility, as they show
a high (approx. 70–90%) compaction ratio at low pressure, but poor compactibility, which may be
seen from the slightly increasing compaction ratios and tensile strengths. Nevertheless, a highly
improved compactibility may be established as result of the composite formation, providing 4 to 6
times higher tensile strength at same compaction ratio than that of the investigated APIs (Figure 8).
On the other hand, despite similar tendencies, the incorporated APIs endowed the composites with
unique characteristics. The highest improvement was observed in the case of DicTi where, in contrast
with the pure API, no tensile strength limitation was noticed, due to the lack of lamination above
85% compaction ratio. DiltTi, where the API was also well incorporated into the composite, showed
similar tablet properties (Figure 6). This indicates considerable predominance of TNTs in systems with
successful composite formation.
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Table 3. Post-compressional properties of the materials.
Material/Pressure
(MPa)
Compaction
Ratio (%)
Breaking
Force (N) SD
Tensile
Strength (MPa) SD
TNT/50 54.94 172.55 2.82 2.35 0.04
TNT/100 60.98 212.72 8.62 3.28 0.09
TNT/150 65.74 274.48 8.23 4.42 0.20
TNT/200 67.29 299.67 8.59 4.78 0.12
TNT/250 69.13 325.56 - 5.58 -
DiltHCl/50 91.37 23.49 1.12 0.47 0.03
DiltHCl/100 93.04 48.49 2.44 1.01 0.07
DiltHCl/150
DiltHCl/200 95.84 60.62 5.98 1.29 0.13
DiltHCl/250
DicNa/50 78.98 23.31 2.08 0.49 0.04
DicNa/100 85.30 42.11 3.86 0.95 0.09
DicNa/150
DicNa/200 92.72 46.42 10.53 0.90 0.33
DicNa/250
ATN/50 84.73 22.30 2.31 0.73 0.07
ATN/100 88.35 24.13 5.00 0.83 0.17
ATN/150
ATN/200 93.48 30.87 4.39 1.12 0.15
ATN/250 94.08 32.38 1.74 1.19 0.06
HCT/50 76.85 16.32 1.02 0.24 0.01
HCT/100 84.08 38.64 1.15 0.64 0.02
HCT/150 86.63 63.44 2.05 1.11 0.02
HCT/200 90.47 85.55 9.03 1.71 0.02
HCT/250
DiltTi/50 67.05 83.33 3.13 0.87 0.03
DiltTi/100 75.15 150.92 6.92 1.90 0.17
DiltTi/150 80.70 248.11 23.15 2.56 0.77
DiltTi/200 83.50 330.98 5.64 4.22 0.13
DiltTi/250 85.89 307.15 - 4.13 -
DicTi/50 63.06 95.61 8.09 1.14 0.10
DicTi/100 73.65 228.63 12.15 2.99 0.27
DicTi/150 79.33 331.09 2.54 4.70 0.37
DicTi/200 86.96 361.03 10.32 6.35 0.54
DicTi/250 90.94 352.93 - 6.07 -
ATNTi/50 70.41 106.01 1.47 1.56 0.02
ATNTi/100 79.06 131.07 6.02 2.16 0.10
ATNTi/150 85.84 129.17 5.97 2.31 0.11
ATNTi/200 88.65 127.86 9.74 2.28 0.13
ATNTi/250 89.83 120.82 - 2.27 -
HCTTi/50 55.10 107.03 3.00 1.50 0.04
HCTTi/100 65.09 214.19 2.93 3.35 0.25
HCTTi/150 71.35 289.66 8.08 5.24 0.15
HCTTi/200 77.30 334.61 23.93 6.56 0.47
HCTTi/250 81.85 393.72 - 8.17 -
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Figure 8. Evaluation of the tensile strength vs. The compaction ratio of the investigated materials
compressed with 50, 100, 150, 200 and 250 MPa compression pressure.
An interesting phenomenon is that HCTTi, where a reverse mechanism of the composite formation
was observed, not only showed far better tablet properties than the other composites, but was very
close to the results of pure TNTs, which was probably the result of the positive consonance of the
reverse interaction HCT and TNTs, and the good compactibility of both constituents. In contrast,
ATNTi displayed relatively bad tablet properties, which proves the important deficiency of the
composite formation, and the induced dominance of the unfavourable compactibility of ATN in
the physical-mixture-like ATNTi product. Nevertheless, it is remarkable that the higher tensile
strength induced by compression of the composites was associated with lower compaction ratios,
which indicates the potential to prepare hard tablets with relatively high porosity, thus providing
benefits for drug release.
4.4. Relation of the Compression Energies and Post-Compressional Properties
The evolution of the breaking energy with the net energy allowed estimation of the efficacy of
compaction through the efficacy coefficient, determined as the slope of the plotted (BW) = f(NCW)
function (Figure 9). In addition, the Ceff values also permitted us to calculate the global yield RT
(Table 2), which presents the option to express the global ability of the powders to be transformed into
cohesive compacts and describe the compaction profile of the materials in a single value, while leaving
the particulars of the compression cycle out of account.
The best RT value was shown by the TNTs, which supports expectations of their exceptional
compressibility, and a considerable improvement in the global yield was observed in the case
of all API–TNT composites in comparison with the pure API, despite the sometimes antinomic
efficacy coefficient values. The only exception was ATN/ATNTi, wherein the inhomogeneous,
physical-mixture-like API–TNT product was predominated by the characteristics of the ATN crystals.
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In regard to the Ceff, TNTs exhibited by far the highest values, thus they proved to have the best
ability to convert net energy into cohesion among the tested materials, despite their relatively low
compaction ratio. In contrast, for the pure APIs the bigger compaction ratio was correlated with higher
Ceff value. This discrepancy may be the explanation for the unexpected results observed for composite
forms. Namely, in the case of DicNa and HCT the composite formation resulted in higher Ceff values,
while decreased efficacy coefficient was detected for the composite forms of DiltHCl and ATN in
comparison with the pure API. This indicates that the Ceff is related to multiplication of the tensile
strength increment rate and the minimal compaction ratio, which provides measurable tablet hardness.
Therefore, it is noteworthy that the Ceff may hide important details, such as the absolute value of tablet
hardness, and may show good results for products where the quality of the API tablets proved to
be doubtful (e.g., laminated or mouldering) in many instances, which hindered the performance of
certain breaking tests and necessitated the estimation of Ceff values from less data (seen for DicNa in
Figure 7). Overall, it can be established that the Ceff value alone is not suitable for the estimation of
powder compactibility, and RT gives a more representative picture of the relationship between the
compression energy and the post-compressional properties of tablets.
5. Conclusions
The present work aimed to investigate the effect of composite formation with TNTs on the
compressibility and compactibility of incorporated APIs, and at the same time to reveal the relevance
of the use of TNTs for tabletting nanocrystalline APIs.
In conclusion, the measurements revealed that TNTs are promising carrier materials, providing
important technological benefits in the field of direct tablet compression. Based on the results, the use
of TNTs has advantages in every step of tabletting. TNTs improved the flowability of the incorporated
APIs, and displayed favourable particle rearrangement in the initial part of the tabletting process.
Furthermore, the presence of TNTs decreased the elastic recovery of the APIs and resulted in good
conversion of energy into plastic deformation. Due to the high feasibility of direct compression of the
composites, not only did the range of compressibility of the APIs become larger through incorporation,
but the post-compressional properties were also found to be more advantageous for the API–TNT
tablets than for the API tablets.
It is remarkable that the presence of TNTs improved the compactibility of the APIs in all
cases, even when the composite formation was incomplete and the product was inhomogeneous.
This observation proves that the processability of TNTs is extremely good, and establishes the idea that
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the TNTs can potentially be used as carriers in the manufacturing of nanocrystalline APIs, and also as
efficient and cheap excipients for any drug in direct tabletting.
Overall, it can be stated that hydrothermally synthesised TNTs are promising carrier materials
that can not only be beneficially used for various biopharmaceutical purposes in medical therapy,
but also for technological objectives in nanocrystalline drug formulation and manufacturing.
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s1.
Author Contributions: Conceptualization: K.P.-H., Z.K. Methodology: M.V.; Formal Analysis: B.S., T.S.;
Investigation: B.S. Resources: M.V., Z.K.; Writing-Original Draft Preparation: B.S.; Writing-Review & Editing:
M.V., K.P.-H., G.R.J., T.S.; Visualization: T.S.; Supervision: T.S.
Funding: This research received no external funding.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Abdullah, M.; Kamarudin, S.K. Titanium dioxide nanotubes (TNT) in energy and environmental applications:
An overview. Renew. Sustain. Energy Rev. 2017, 76, 212–225. [CrossRef]
2. Li, M.; Xiao, X.; Fan, X.; Huang, X.; Liu, Y.; Chen, L. Carbon coated sodium-titanate nanotube as an advanced
intercalation anode material for sodium-ion batteries. J. Alloy. Compd. 2017, 712, 365–372. [CrossRef]
3. Tran, V.A.; Truong, T.T.; Phan, T.A.P.; Nguyen, T.N.; Huynh, T.V.; Agresti, A.; Pescetelli, S.; Le, T.K.;
Di Carlo, A.; Lund, T.; et al. Application of nitrogen-doped TiO2 nano-tubes in dye-sensitized solar cells.
Appl. Surf. Sci. 2017, 399, 515–522. [CrossRef]
4. Wang, J.; Li, W.; Ge, Y.; Shen, J.; Zhao, Y.; Zhang, Y.; Yuan, J. Design and synthesis of porous TiO2@C nanotube
bundles with enhanced supercapacitive performance. Ceram. Int. 2017, 43, 2876–2880. [CrossRef]
5. Yee, M.S.-L.; Khiew, P.S.; Lim, S.S.; Chiu, W.S.; Tan, Y.F.; Kok, Y.-Y.; Leong, C.-O. Enhanced marine
antifouling performance of silver-titania nanotube composites from hydrothermal processing. Colloids Surf.
A Physicochem. Eng. Asp. 2017, 520, 701–711. [CrossRef]
6. Awad, N.K.; Edwards, S.L.; Morsi, Y.S. A review of TiO2 NTs on Ti metal: Electrochemical synthesis,
functionalization and potential use as bone implants. Mater. Sci. Eng. C 2017, 76, 1401–1412. [CrossRef]
[PubMed]
7. Huang, Y.; Xu, Z.; Zhang, X.; Chang, X.; Zhang, X.; Li, Y.; Ye, T.; Han, R.; Han, S.; Gao, Y.; et al.
Nanotube-formed Ti substrates coated with silicate/silver co-doped hydroxyapatite as prospective materials
for bone implants. J. Alloy. Compd. 2017, 697, 182–199. [CrossRef]
8. Mangayayam, M.; Kiwi, J.; Giannakis, S.; Pulgarin, C.; Zivkovic, I.; Magrez, A.; Rtimi, S. FeOx magnetization
enhancing E. coli inactivation by orders of magnitude on Ag-TiO2 nanotubes under sunlight. Appl. Catal.
B Environ. 2017, 202, 438–445. [CrossRef]
9. Nador, J.; Orgovan, N.; Fried, M.; Petrik, P.; Sulyok, A.; Ramsden, J.J.; Korosi, L.; Horvath, R. Enhanced
protein adsorption and cellular adhesion using transparent titanate nanotube thin films made by a simple
and inexpensive room temperature process: Application to optical biochips. Colloids Surf. B Biointerfaces
2014, 122, 491–497. [CrossRef] [PubMed]
10. Sree Latha, T.; Reddy, M.C.; Muthukonda, S.V.; Srikanth, V.V.S.S.; Lomada, D. In vitro and in vivo evaluation
of anti-cancer activity: Shape-dependent properties of TiO2 nanostructures. Mater. Sci. Eng. C 2017, 78,
969–977. [CrossRef] [PubMed]
11. Fernández-Werner, L.; Pignanelli, F.; Montenegro, B.; Romero, M.; Pardo, H.; Faccio, R.; Mombrú, Á.W.
Characterization of titanate nanotubes for energy applications. J. Energy Storage 2017, 12, 66–77. [CrossRef]
12. Preda, S.; Rutar, M.; Umek, P.; Zaharescu, M. A study of thermal properties of sodium titanate nanotubes
synthesized by microwave-assisted hydrothermal method. Mater. Res. Bull. 2015, 71, 98–105. [CrossRef]
13. Feng, W.; Geng, Z.; Li, Z.; Cui, Z.; Zhu, S.; Liang, Y.; Liu, Y.; Wang, R.; Yang, X. Controlled release behaviour
and antibacterial effects of antibiotic-loaded titania nanotubes. Mater. Sci. Eng. C 2016, 62, 105–112.
[CrossRef] [PubMed]
Materials 2018, 11, 2582 15 of 15
14. Peng, J.; Zhang, X.; Li, Z.; Liu, Y.; Yang, X. Titania nanotube delivery fetal bovine serum for enhancing
MC3T3-E1 activity and osteogenic gene expression. Mater. Sci. Eng. C 2015, 56, 438–443. [CrossRef]
[PubMed]
15. Wang, T.; Weng, Z.; Liu, X.; Yeung, K.W.K.; Pan, H.; Wu, S. Controlled release and biocompatibility of
polymer/titania nanotube array system on titanium implants. Bioact. Mater. 2017, 2, 44–50. [CrossRef]
[PubMed]
16. Khoshnood, N.; Zamanian, A.; Massoudi, A. Mussel-inspired surface modification of Titania nanotubes as a
novel drug delivery system. Mater. Sci. Eng. C 2017, 77, 748–754. [CrossRef] [PubMed]
17. Wang, Z.; Xie, C.; Luo, F.; Li, P.; Xiao, X. P25 nanoparticles decorated on titania nanotubes arrays as effective
drug delivery system for ibuprofen. Appl. Surf. Sci. 2015, 324, 621–626. [CrossRef]
18. Fenyvesi, F.; Kónya, Z.; Rázga, Z.; Vecsernyés, M.; Kása, P.; Pintye-Hódi, K.; Bácskay, I. Investigation of the
cytotoxic effects of titanate nanotubes on Caco-2 cells. AAPS PharmSciTech 2014, 15, 858–861. [CrossRef]
[PubMed]
19. Wadhwa, S.; Rea, C.; O’Hare, P.; Mathur, A.; Roy, S.S.; Dunlop, P.S.M.; Byrne, J.A.; Burke, G.; Meenan, B.;
McLaughlin, J.A. Comparative in vitro cytotoxicity study of carbon nanotubes and titania nanostructures on
human lung epithelial cells. J. Hazard. Mater. 2011, 191, 56–61. [CrossRef] [PubMed]
20. Sipos, B.; Pintye-Hódi, K.; Kónya, Z.; Kelemen, A.; Regdon, G., Jr.; Sovány, T. Physicochemical
characterisation and investigation of the bonding mechanisms of API-titanate nanotube composites as
new drug carrier systems. Int. J. Pharm. 2017, 518, 119–129. [CrossRef] [PubMed]
21. Li, Q.; Chen, L.; Gadinski, M.R.; Zhang, S.; Zhang, G.; Li, U.; Iagodkine, E.; Haque, A.; Chen, L.Q.; Jackson, N.;
et al. Flexible high-temperature dielectric materials from polymer nanocomposites. Nature 2015, 523, 576–579.
[CrossRef] [PubMed]
22. Jeong, C.K.; Baek, C.; Kingon, A.I.; Park, K.-I.; Kim, S.-H. Lead-Free Perovskite Nanowire-Employed
Piezopolymer for Highly Efficient Flexible Nanocomposite Energy Harvester. Small 2018, 14, e1704022.
[CrossRef] [PubMed]
23. Heckel, R.W. Density–pressure relationships in powder compaction. Trans. Metall. Soc. AIME 1961, 221,
671–675.
24. Heckel, R.W. An Analysis of powder compaction phenomena. Trans. Metall. Soc. AIME 1961, 221, 1001–1008.
25. Walker, E.E. The properties of powder. Part VI. The compressibility of powders. Trans. Faraday Soc. 1923, 19,
73–82. [CrossRef]
26. Kawakita, K.; Lüdde, K.H. Some considerations on powder compaction equations. Powder Technol. 1971, 4,
61–68. [CrossRef]
27. Hellrup, J.; Nordström, J.; Mahlin, D. Powder compression mechanics of spray-dried lactose nanocomposites.
Int. J. Pharm. 2017, 518, 1–10. [CrossRef] [PubMed]
28. Mallick, S. Rearrangement of particle and compactibility, tabletability and compressibility of pharmaceutical
powder: A rational approach. J. Sci. Ind. Res. 2014, 73, 51–56.
29. Persson, A.S.; Nordström, J.; Frenning, G.; Alderborn, G. Compression analysis for assessment of pellet
plasticity: Identification of reactant pores and comparison between Heckel, Kawakita, and Adams equations.
Chem. Eng. Res. Des. 2016, 110, 183–191. [CrossRef]
30. Sonnergaard, J.M. A critical evaluation of Heckel equation. Int. J. Pharm. 1999, 193, 63–71. [CrossRef]
31. Viana, M.; Ribet, J.; Rodriguez, F.; Chulia, D. Powder Functionality Test: A Methodology for Rheological and
Mechanical Characterization. Pharm. Dev. Technol. 2005, 10, 327–338. [CrossRef] [PubMed]
32. Stamm, A.; Mathis, C. Verprelssbarkeit von festen Hilf- stoffen für Direkttablettierung. Acta Pharm. Technol.
1976, 22, 7–16.
33. Viana, M.; Jouannin, P.; Pontier, C.; Chulia, D. About pycnometric density measurements. Talanta 2002, 57,
583–593. [CrossRef]
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
